Philips and Infraredx Inc. announced a non-exclusive resale agreement for Infraredx’s TVC imaging system. Under the terms of the agreement, Philips will sell Infraredx’s TVC imaging system alongside its Allura interventional X-ray systems in North America and Europe.

The findings of a Harvey L. Neiman Health Policy Institute study published online in the Journal of the American College of Radiology (JACR) confirm a major shift in practice at American hospitals regarding central venous procedures.

OrbusNeich announced the publication of a study demonstrating that lesion preparation with the company’s Scoreflex coronary dilatation catheter prior to drug eluting stent (DES) implantation is associated with equivalent acute stent expansion and less in-stent late loss versus a non-compliant balloon.

Nonin Medical Inc., the inventor of finger pulse oximetry and a leader in noninvasive medical monitoring, announced that the U.S. Food and Drug Administration (FDA) has cleared the Nonin Model 3230 Bluetooth Smart finger pulse oximeter for use in the United States.

Biotronik Japan announced enrollment of the first patient in the Bioflow-IV study, which aims to verify the efficacy and safety of the Orsiro Hybrid Drug-Eluting Stent (DES) from Biotronik.

The American Society of Echocardiography (ASE) Foundation is announced the Echo AUC, a new mobile application that is designed to guide physicians in appropriate procedures in cardiovascular care and echocardiography, is available for download in both the Apple and Droid application stores.

Alivecor Inc. announced that the AliveCor Heart Monitor is now being offered to participants in the Health eHeart Study with 2,000 units to be deployed before the end of the year. 

Researchers at The University of Texas Health Science Center at Houston (UTHealth) led a study that showed that a hands-free ultrasound device, combined with a clot-busting drug, was safe for ischemic stroke patients.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now